JEROME DIXON: Open Payments
NPI 1215919451 · CAMPBELLSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 21 payments from 10 companies in 2025. Trend: 2023 $466 · 2024 $390 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $105 |
| Lundbeck LLC | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Indivior Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: FANAPT, REXULTI, CAPLYTA, SUBLOCADE, VOQUEZNA, JARDIANCE, Kerendia, TRINTELLIX.
Industry payments across KY — which companies pay providers there.
